KL003 Cell Injection Drug Product

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Transfusion-dependent Beta-Thalassemia

Drug Information

Target Indication

Transfusion-dependent Beta-Thalassemia

Clinical Trial

Last updated: 6/26/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

BTMD

biote Corp.

Related Pipeline

Metastatic Renal Cell Carcinoma

Systemic Sclerosis

Refractory Cancer

Lupus Nephritis

Non-small Cell Lung Cancer

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts